Abstract:Background Vascular dementia (VD) is the second most common type of dementia after Alzheimer's disease. β-asarone, a major component of Acorus tatarinowii Schott , is important in neurodegenerative and neurovascular diseases. Studies have confirmed that β-asarone can mitigate autophagy and reduce damage in hypoxic cells. We also reported that β-asarone improves learning and memory. This study further clarifies whether β-asarone attenuates cerebral ischaemic injury by acting through the cAMP/PKA/CREB pathway in VD model mice. Methods Here, genes and potential pathways that may be targeted by β-asarone for the treatment of transient cerebral ischaemia (TCI) and cognitive impairment (CI) were obtained using network pharmacology. The two-vessel occlusion method was used to establish the VD model. The Morris water maze test was used to evaluate the effects on memory. Then, the protein levels of mitofusin-2 (Mfn2), brain-derived neurotrophic factor (BDNF), optic atrophy 1 (OPA1), cyclic adenosine monophosphate (cAMP), myelin basic protein (MBP), matrix metalloproteinase-9 (MMP9) and neuron specific enolase (NSE) were determined by ELISA. The levels of superoxide dismutase (SOD) and malonaldehyde (MDA) were measured using commercial kits. Then, qRT-PCR was employed to investigate the expression of the candidate genes screened from the protein-protein interaction (PPI) network. Furthermore, the expression of the autophagy-related proteins Beclin-1, (microtubule-associated protein light chain 3) LC3, p62, postsynaptic density protein 95 (PSD95), protein kinase A (PKA), pPKA, cyclic-AMP response binding protein (CREB), and pCREB was determined by western blotting. The expression of autophagy-related proteins, PSD95 and translocase of outer mitochondrial membrane 20 (TOM20) was determined by immunofluorescence analyses. Results The network pharmacological analysis showed 234 targets related to β-asarone, 1,118 genes related to TCI and 2,039 genes associated with CI. Our results confirm that β-asarone treatment not only alleviated brain damage in the VD model by improving mitochondrial and synaptic function, reducing neuronal injury and upregulating the expression of antioxidants but also effectively improved the cognitive behaviour of VD model mice. Moreover, β-asarone downregulated VD-induced RELA and CCND1 mRNA expression. In addition, we validated that β-asarone increased the phosphorylation of PKA and CREB and upregulated cAMP protein expression. The results showed that the cAMP/PKA/CREB signalling pathway was upregulated. Moreover, β-asarone administration decreased the protein expression levels of Beclin-1 and LC3 and increased the expression levels of p62 in VD model mice. Conclusions β-asarone inhibits Beclin-1-dependent autophagy and upregulates the cAMP/PKA/CREB signalling pathway to attenuate mitochondrial and synaptic damage from cerebral ischaemia and improve learning and cognitive abilities in VD model mice.

Sarsasapogenin‐AA13 Ameliorates Aβ‐induced Cognitive Deficits Via Improving Neuroglial Capacity on Aβ Clearance and Antiinflammation

Astrocytes Mediated the Nootropic and Neurotrophic Effects of Sarsasapogenin-AA13 Via Upregulating Brain-Derived Neurotrophic Factor.

Sarsasapogenin attenuates Alzheimer-like encephalopathy in diabetes

Neuroprotective effects of sarsasapogenin-AA 13 via autophagy and MAPK pathway

Sarsasapogenin ameliorates diabetes‐associated memory impairment and neuroinflammation through down‐regulation of PAR ‐1 receptor

P23 Saikosaponin a Ameliorate Learning and Memory Impairment Via Anti-Inflammation Effect in an AD Mouse Model

Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Aβ42, P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus

Esculentoside A Suppresses Aβ1–42-induced Neuroinflammation by Down-Regulating MAPKs Pathwaysin Vivo

Neuroprotective Effect of Β-Asarone Against Alzheimer’s Disease: Regulation of Synaptic Plasticity by Increased Expression of SYP and GluR1

Akebia Saponin D Attenuates Amyloid Β-Induced Cognitive Deficits and Inflammatory Response in Rats: Involvement of Akt/NF-κB Pathway

Ganoderic Acid A Promotes Amyloid-β Clearance (In Vitro) and Ameliorates Cognitive Deficiency in Alzheimer’s Disease (Mouse Model) Through Autophagy Induced by Activating Axl

Treatment with Akebia Saponin D Ameliorates Aβ1–42-Induced Memory Impairment and Neurotoxicity in Rats

Β-Asarone Inhibits Neuronal Apoptosis Via the CaMKII/CREB/Bcl-2 Signaling Pathway in an in Vitro Model and AβPP/PS1 Mice

Design, Synthesis and Biological Evaluation of 3-Piperazinecarboxylate Sarsasapogenin Derivatives As Potential Multifunctional Anti-Alzheimer Agents.

β-Asarone Inhibits Amyloid-β by Promoting Autophagy in a Cell Model of Alzheimer's Disease

S -Propargyl-cysteine (ZYZ-802), a Sulphur-Containing Amino Acid, Attenuates Beta-Amyloid-induced Cognitive Deficits and Pro-Inflammatory Response: Involvement of ERK1/2 and NF-κB Pathway in Rats

Saikogenin F from Bupleurum Smithii Ameliorates Learning and Memory Impairment Via Antiinflammation Effect in an Alzheimer's Disease Mouse Model

β-asarone improves cognitive impairment and alleviates autophagy in mice with vascular dementia via the cAMP/PKA/CREB pathway.

Sarsasapogenin-Aa13 Inhibits Lps-Induced Inflammatory Responses in Macrophage Cells in Vitro and Relieves Dimethylbenzene-Induced Ear Edema in Mice

Sarsasapogenin suppresses Aβ overproduction induced by high glucose in HT-22 cells

An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.